Tamoxifen: Pharmacokinetics and Pharmacodynamics
- Publisher:
- Medwin Publishers
- Publication Type:
- Journal Article
- Citation:
- Open Access Journal of Pharmaceutical Research, 2017, 1 (8), pp. 1 - 8 (8)
- Issue Date:
- 2017-12-01
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| OAJPR16000143 (8).pdf | Published Version | 680.54 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Tamoxifen is the hormone therapy of choice in pre-menopausal estrogen receptor positive breast cancer in women and sometimes in post-menopausal women. The environmental and genetic factors widely affect the pharmacokinetic parameters of a drug and this effect is known as pharmgeonetics. The pharmacokinetic parameters that are what a body does with the drug, such as bioavailability, half-life, distribution and excretion, has primary importance in the treatment of a disease. The pharmacodynamic parameters which elaborate what a drug does with the body like side effects and positive symptoms are the pillars of therapeutic outcome. In depth knowledge of both parameters is essential to get maximum benefits from a treatment plan in a disease for example breast cancer. This review enlightens the pharmacological aspects of tamoxifen in detail.
Please use this identifier to cite or link to this item: